Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Oxybutynin Transdermal Patch
Oral Oxybutynin
Locations
1
United States
University of California Davis Medical Center (UCDMC)
Sacramento, California, United States
Start Date
September 1, 2021
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
January 29, 2026
NCT04873037
NCT06094543
NCT06198439
NCT06212661
NCT06769854
NCT03535857
Lead Sponsor
University of California, Davis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions